Indian Ambassador visited Novavax. Novavax is headquartered in Gaithersburg, Maryland. It is a biotechnology company that develops and commercializes vaccines to prevent infectious diseases.
Washington.America Ambassador of India to Taranjit Singh Sandhu big pharmaceutical company novavax Center on Friday and said that its partnership with Serum Institute of India (SII) is a testament to the strong cooperation in the field of healthcare between India and the US. Novavax is headquartered in Gaithersburg, Maryland. It is a biotechnology company that develops and commercializes vaccines to prevent infectious diseases.
Sandhu told Stanley C. Erk, President, CEO and Director, Novavax that the partnership between Novavax and SII is a “strong partnership between India and the US in the field of healthcare cooperation, especially in the context of making affordable and accessible vaccines and drugs.” Another example of ‘. Erk told the ambassador that the COVID-19 vaccine is very effective based on the trials conducted so far. Novavax announced in January 2020 to develop an anti-coronavirus vaccine.
Subsequently, Novavax and India’s SII entered into a vaccine manufacturing agreement, under which the Novavax vaccine is likely to be distributed as Kovavax in India. Novavax announced on June 14 that the vaccine was up to 90.4 percent effective in Phase III trials in the US and Mexico. Sandhu said that the healthcare sectors of both the countries are cooperating through joint research, sharing of technical expertise and knowledge exchange.
Disclaimer:Prabhasakshi has not edited this news. This news has been published from PTI-language feed.